The LSG Viral Inactivation Buffer (VIB) has been developed in collaboration with the University of Bedfordshire. It has been formulated to provide a buffer that will inactivate viruses responsible for pandemics such as Covid-19 and seasonal influenza and epidemics such as SARS, MERS and Ebola.
This product has been developed to inactivate the pathogen in the transport tube containing a patient sample, to lyse cells and denature any virus in the sample, rendering the virus inactive and nonpathogenic. This results in a non-pathogenic sample for transport and testing with the added advantage that viral samples are destabilised due to the denaturation of degrading enzymes that may be present. Samples do not need to be maintained at +4°C, removing the requirement for a cold chain in handling and thereby greatly reducing transport costs.
Life Science Production (LSP) is a Division of Life Science Group Ltd (LSG). LSP is a privately owned UK company providing a range of quality foetal bovine serum, Human AB serum, other cell culture sera, media and reagents together with Custom Manufacturing services of serum, buffers, and media.